124 related articles for article (PubMed ID: 28590550)
61. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
[TBL] [Abstract][Full Text] [Related]
62. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
[TBL] [Abstract][Full Text] [Related]
63. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
64. CD28 superagonist antibody treatment attenuated obliterative bronchiolitis in rat allo-orthotopic tracheal transplantation by preferentially expanding Foxp3-expressing regulatory T cells.
Shi Q; Niu Y; Cao H; Zhou X; Jiang S; Liu Z; Fan H
Transplant Proc; 2012 May; 44(4):1060-6. PubMed ID: 22564625
[TBL] [Abstract][Full Text] [Related]
65. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
[TBL] [Abstract][Full Text] [Related]
66. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
Nguyen VH; Zeiser R; Negrin RS
Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
[TBL] [Abstract][Full Text] [Related]
67. High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants.
Lu SY; Huang XJ; Liu KY; Liu DH; Xu LP
Clin Transplant; 2012; 26(2):E158-67. PubMed ID: 22507356
[TBL] [Abstract][Full Text] [Related]
68. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
69. Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD.
Zhai Z; Sun Z; Li Q; Zhang A; Liu H; Xu J; Xu X; Geng L; Harris D; Hu S; Wang Y
Transpl Int; 2007 May; 20(5):440-6. PubMed ID: 17313446
[TBL] [Abstract][Full Text] [Related]
70. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.
Blazar BR; Taylor PA; Snover DC; Sehgal SN; Vallera DA
J Immunol; 1993 Nov; 151(10):5726-41. PubMed ID: 8228258
[TBL] [Abstract][Full Text] [Related]
71. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
[TBL] [Abstract][Full Text] [Related]
72. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
[TBL] [Abstract][Full Text] [Related]
73. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
[TBL] [Abstract][Full Text] [Related]
74. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
Huang H; Zheng W; Lin M; Fu J; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):191-3. PubMed ID: 12133455
[TBL] [Abstract][Full Text] [Related]
75. CD8
Chen J; Zhuang L; Li Y; Wu K; Duan Y; Feng J; Sun D; Qu Z; Shi L
Transpl Immunol; 2023 Apr; 77():101805. PubMed ID: 36841514
[TBL] [Abstract][Full Text] [Related]
76. Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: A report of 11cases.
Zhao XF; Lin DD; Li N; Wu JS; Guo QL; Wang L
Transpl Immunol; 2020 Oct; 62():101307. PubMed ID: 32540505
[TBL] [Abstract][Full Text] [Related]
77. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.
Engelhardt BG; Sengsayadeth SM; Jagasia M; Savani BN; Kassim AA; Lu P; Shyr Y; Yoder SM; Rock MT; Crowe JE
Exp Hematol; 2012 Dec; 40(12):974-982.e1. PubMed ID: 22885125
[TBL] [Abstract][Full Text] [Related]
78. The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation.
Schuchmann M; Meyer RG; Distler E; von Stebut E; Kuball J; Schnürer E; Wölfel T; Theobald M; Konur A; Gregor S; Schreiner O; Huber C; Galle PR; Otto G; Herr W
Am J Transplant; 2008 Nov; 8(11):2434-44. PubMed ID: 18925909
[TBL] [Abstract][Full Text] [Related]
79. Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin.
Wu KN; Emmons RV; Lisanti MP; Farber JL; Witkiewicz AK
Cell Cycle; 2009 Nov; 8(21):3601-5. PubMed ID: 19838066
[TBL] [Abstract][Full Text] [Related]
80. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function.
Ulbar F; Montemurro T; Jofra T; Capri M; Comai G; Bertuzzo V; Lavazza C; Mandelli A; Viganò M; Budelli S; Bacalini MG; Pirazzini C; Garagnani P; Giudice V; Sollazzo D; Curti A; Arpinati M; La Manna G; Cescon M; Pinna AD; Franceschi C; Battaglia M; Giordano R; Catani L; Lemoli RM
J Transl Med; 2019 Aug; 17(1):250. PubMed ID: 31383037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
